Recombinant Proteins Market Players:
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck KGaA
- Lonza Group AG
- GenScript Biotech Corporation
- AbbVie Inc.
- Amgen Inc.
- Roche Holdings Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of recombinant proteins is estimated at USD 3.26 billion.
The global recombinant proteins market size was more than USD 3.01 billion in 2025 and is anticipated to witness a CAGR of over 9.2%, crossing USD 7.26 billion revenue by 2035.
North America recombinant proteins market will secure around 35% share by 2035, driven by growing population, research activity, and health insurance coverage.
Key players in the market include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, GenScript Biotech Corporation, AbbVie Inc., Amgen Inc., Roche Holdings Inc., Novartis AG, Pfizer Inc., Sanofi SA.
